Clinical decision support
Two variants of the Annalise CXR Edge products will be offered in Australia.
The AI platform can predict a person's risk of having a stroke or a heart attack in the next five years.
The AI system can also classify abnormal tissues as malignant or benign.
The company develops a breakthrough device for detecting residual cancer tissues.
The clinical trial with Huntsville Heart Center is expected to be completed by October.
The AI tech can spot signs of pancreatic cancer from non-contrast CT images.
It plans to develop an in-house cloud platform.
Also, Intuitive India releases its mobile app for surgeons using the da Vinci RAS system.
The system is trained with over 150 subjects to accurately locate human bone landmark locations.
The Series C comes about two years after another $150 million raise.